INSIGHTS ON DRUG DEVELOPMENT

• Formulation And Analytical Tour

  Take a brief tour of Nanoform’s advanced nanoformulation, nanoanalytical, and best-in-class capabilities.

• Simplify Process Scale-Up With An Innovative Single-Use Bioreactor

  Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.

• Automating High-Throughput Screens Using Patient-Derived Organoids

  Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

• Predicting Hepatotoxicity With The Liver-Chip

  Enhance your understanding of liver organoids and their pivotal role in enhancing DILI risk prediction through the use of advanced Organ-Chip technology.

• Aggregate Analysis Of Semaglutide

  12/11/2025

  Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

• Highly Sensitive ELISAs In 90 Minutes

  9/11/2024

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.

• Assessing Viability And Real-Time Apoptosis/Necrosis

  3/17/2025

  Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.

• Nose To Brain (N2B) Drug Delivery – Benefits And Challenges

  11/20/2024

  Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

• Is Lipinski's Rule Of Five Still Relevant In Drug Development?

  11/13/2024

  Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.